Target intelligence / Profile preview

Ethylmalonyl-CoA decarboxylase (ECHDC1)

Target
ECHDC1
Molecular classification
Enzyme, Enoyl-CoA hydratase family
01

Overview

Ethylmalonyl-CoA decarboxylase (ECHDC1) is a cytosolic enzyme that catalyzes the decarboxylation of (S)-ethylmalonyl-CoA to butyryl-CoA and CO₂, and to a lesser extent converts methylmalonyl-CoA to propionyl-CoA[2][3][4][6]. ECHDC1 plays a specialized role in metabolite proofreading, which removes non-physiological and potentially toxic byproducts generated by the side activity of major lipid metabolism enzymes such as acetyl-CoA and propionyl-CoA carboxylases[3][2][6]. Loss or deficiency of ECHDC1 can result in an accumulation of ethylmalonic acid, a phenotype associated with ethylmalonic aciduria, particularly when combined with known ACADS mutations[1][3]. The protein is most abundant in brown adipose tissue, liver, and kidney in mice, and is essentially cytosolic[3]. ECHDC1 belongs to the enoyl-CoA hydratase/isomerase family but displays high substrate specificity for ethylmalonyl-CoA, and lacks significant hydratase or thioesterase activity[2][3][4]. Currently, there are no known small-molecule drugs that directly target ECHDC1 for therapeutic purposes.

Other names
Enoyl-CoA hydratase domain-containing protein 1Methylmalonyl-CoA decarboxylaseMMCDdJ351K20.2Enoyl CoA hydratase domain containing 1Enoyl Coenzyme A hydratase domain containing 1Epididymis secretory protein Li 76HEL-S-76
02

Biological functions

Metabolite proofreadingFatty acid metabolismDecarboxylation of ethylmalonyl-CoAPrevention of toxic metabolite accumulation
03

Disease associations

Ethylmalonic aciduriaPotential synergistic contribution to metabolic disease when co-inherited with ACADS mutations
04

Biomarkers

Elevated ethylmalonic acid (EMA) levels (for detection of metabolic defects or ECHDC1 deficiency)

Beyond the preview

Go deeper on Ethylmalonyl-CoA decarboxylase (ECHDC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ethylmalonyl-CoA decarboxylase (ECHDC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call